Background: Multiple allergens have been documented in soybean extracts. IgE from individuals allergic to soybeans, but not to peanut, has been shown by immunoblot analysis to bind to proteins with a molecular weight of approximately 22 kD. These findings suggested that this unique protein fraction from soybean might be responsible, in part, for soybean allergic reactivity. The objective of the present study was to characterize specific B cell epitopes, to determine if any amino acid was critical to IgE binding and to model the 22-kD G2 soybean allergen to the three-dimensional (3-D) phaseolin molecule. Methods: B cell epitopes were identified using SPOTs peptide analysis. Structural orientation of the IgE-binding regions was mapped to the 3-D phaseolin molecule using molecular modeling of the protein tertiary structure. Results: Eleven linear epitopes, representing 15 amino acid peptide sequences, bound to IgE in the glycinin molecule. These epitopes were predicted to be distributed asymmetrically on the surface of G2 trimers. Conclusions: Only 1 epitope could be rendered non-IgE binding by alanine substitutions in the peptide. The nonrandom distribution of the IgE binding sites provides new insight into their organization in trimers in 11S complexes of the G2 glycinin allergen.

1.
Gajhede M, Osmark P, Poulsen FM, Ipsen H, Larsen JN, Joost van Neerven RJ, Schou C, Lowenstein H, Spangfort MD: X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996;3:1040–1045.
2.
Fedorov AA, Ball T, Mahoney NM, Valenta R, Almo SC: The molecular basis for allergen cross-reactivity: Crystal structure and IgE-epitope mapping of birch pollen profilin. Structure 1997;5:33–45.
3.
Thorn KS, Christensen HE, Shigeta R, Huddler D, Shalaby L, Lindberg U, Chua NH, Schutt CE: The crystal structure of a major allergen from plants. Structure 1997;5:19–32.
4.
Fedorov AA, Ball T, Valenta R, Almo SC: X-ray crystal structure of birch pollen profilin and Phl p 2. Int Arch Allergy Immunol 1997;113:109–113.
5.
Eigenmann PA, Burks AW, Bannon GA, Sampson HA: Identification of unique peanut and soy allergens in sera adsorbed with cross-reacting antibodies. J Allergy Clin Immunol 1996;98:969–978.
6.
Herian AM, Taylor SL, Bush RK: Identification of soybean allergens by immunoblotting with sera from soy-allergic adults. Int Arch Allergy Appl Immunol 1990;92:193–198.
7.
Helm RM, Cockrell G, Connaughton C, Sampson HA, Bannon GA, Beilinson V, Livingstone D, Nielsen NC, Burks AW: A soybean G2 glycinin allergen. 1. Identification and characterization. Int Arch Allergy Immunol 2000;123:205–212.
8.
Nielsen NC, Bassuner R, Beaman T: The biochemistry and cell biology of embryo storage proteins; in Larkins BA, Vasil K (eds): Cellular and Molecular Biology of Plant Seed Development. Boston, Kluwer Academic, 1997, pp 151–220.
9.
Staswick PE, Hermodson MA, Nielsen NC: The amino acid sequence of the A2B1a subunit of glycinin. J Biol Chem 1984;259:13424–13430.
10.
Pedersen HS, Djurtoft R: Antigenic and allergenic properties of acidic and basic peptide chains from glycinin. Food Agric Immunol 1989;1:101–109.
11.
Djurtoft R, Pedersen HS, Aabin B, Barkholt V: Studies of food allergens: Soybean and egg proteins. Adv Exp Med Biol 1991;289:281–293.
12.
Zeece MG, Beardslee TA, Markwell JJP, Sarath G: Identification of an IgE-binding region in soybean acidic glycinin G1. Food Agric Immunol 1999;11:83–90.
13.
Lawrence MC, Izard T, Beuchat M, Blagrove RJ, Colman PM: Structure of phaseolin at 2.2 A resolution. Implications for a common vicilin/legumin structure and the genetic engineering of seed storage proteins. J Mol Biol 1994; 238:748–776.
14.
Sayle RA, Milner-White EJ: RASMOL: Biomolecular graphics for all. Trends Biochem Sci 1995;20:374–376.
15.
Guex N, Peitsch MC: SWISS-MODEL and Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997;18:14–23.
16.
Stanley JS, Helm RM, Cockrell G, Burks AW, Bannon GA: Peanut hypersensitivity: IgE binding characteristics of a recombinant Ara h 1 protein. Adv Exp Med Biol 1996;409:213–216.
17.
Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW, Bannon GA: Molecular cloning and epitope analysis of the peanut allergen, Ara h 3. J Clin Invest 1999;103:535–542.
18.
Argos P, Narayana SVL, Nielsen NC: Structural similarity between legumin and vicilin storage proteins from legumes. EMBO J 1985;4:1111–1117.
19.
Adachi M, Masuda T, Mikami B, Utsumi S: Crystal structures of soybean proglycinin A1 aB1 b and A3B4 homotrimers. XVI Int. Bot. Congress, St. Louis, 1999, Abstract 5871.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.